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Single site OH / F substitution at the termini of maltotetraose leads to significantly improved hydrolytic
stability towards a-amylase and a-glucosidase relative to the natural compound. To explore the effect of
molecular editing, selectively modified oligosaccharides were prepared via a convergent a-selective
strategy. Incubation experiments in purified a-amylase and a-glucosidase, and in human and murine
blood serum, provide insight into the influence of fluorine on the hydrolytic stability of these clinically
important scaffolds. Enhancements of ca. 1 order of magnitude result from these subtle single point
mutations. Modification at the monosaccharide furthest from the probable enzymatic cleavage termini
leads to the greatest improvement in stability. In the case of a-amylase, docking studies revealed that
retentive C2-fluorination at the reducing end inverts the orientation in which the substrate is bound. A
co-crystal structure of human a-amylase revealed maltose units bound at the active-site. In view of the
evolving popularity of C(sp3)–F bioisosteres in medicinal chemistry, and the importance of maltodextrins
in bacterial imaging, this discovery begins to reconcile the information-rich nature of carbohydrates with
their intrinsic hydrolytic vulnerabilities.Introduction
The abundance of carbohydrates in biology, together with
their structural and functional diversity,1 has resulted in
a highly specic arsenal of regulatory enzymes.2 This molec-
ular synergy spans the animal, plant and bacteria kingdoms,
and manifests itself in processes ranging from subtle post-ster, Corrensstraße 36, 48149 Münster,
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of Chemistry 2020translational modications to the high-throughput meta-
bolic processes that are essential for life.3 As workhorses in
processing carbohydrate energy sources, the venerable
glycoside hydrolases play an essential role in breaking down
long-chain glycans into their respective building blocks.4 A
pertinent example is the endo-hydrolysis of a-(1 / 4) linked
maltodextrins.5 These processes, underpinned by a unique
molecular recognition partnership, are essential and
repeated iteratively with remarkable precision and delity.
Regrettably, this juxtaposition of selectivity and intrinsic
hydrolytic instability continues to frustrate translational
advances to the clinic6 due to the inherent instability of the
glycan in vivo: this is particularly relevant in the context of
bacterial infections. Specically, 18F-labelled oligosaccha-
rides have shown great potential due to their selective uptake
in prokaryotic (bacterial) cells.7 However, achieving sufficient
serum circulation times for maltodextrin PET tracers, to
enable satisfactory signal-to-noise ratios, requires the devel-
opment of metabolically robust scaffolds that are subtly
modied so as not to disrupt molecular recognition.8
Molecular orientation is a characteristic feature in glyco-
side hydrolysis with substrates being processed from
a specic terminus.9 From the perspective of clinical trans-
lation, one conceptual strategy to mitigate this hydrolytic
vulnerability is to alter substrate orientation in the enzyme
pocket without inhibiting recognition completely (Fig. 1).Chem. Sci.
Fig. 1 Conceptual framework of this study to validate the preclinical
potential of fluorination in rendering tetraoses imaging platforms for
bacterial infection.
Fig. 3 The maltotetraose probe set for this study.
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View Article OnlineFluorine bioisosteres are ideally suited to this purpose,10,11
allowing localised changes to the physicochemical prole of
the substrate to be introduced without a dominant steric
penalty that would impede recognition completely.12 To
expand our interest in modulating small molecule–protein
interactions,13 the effect of site-selective uorination on the
hydrolysis of maltotetraoses by a-amylases and a-glucosi-
dases is disclosed (Fig. 2).14
Consequently, a series of novel tetrasaccharide probes (1–6)
were conceived to explore the inuence of subtle changes in
site-selective uorine introduction [C(sp3)–OH vs. C(sp3)–F] on
hydrolytic stability (Fig. 3).
Strategic uorination has a venerable history in the study
and inhibition of hydrolases, but, to the best of our knowledge,
has never been extended to the maltotetraoses. The maltote-
traose core (1) was selected for this analysis since it is the
shortest maltodextrin that can be truncated by salivary a-amy-
lase.7b,15 Inspired by Withers' pioneering mono-, di- and tri-
saccharide mechanistic enzymology tools,16,17 molecular edit-
ing at the C2 position of the terminal monosaccharides was
performed. It was envisaged that this would enable an elec-
tronic inuence to be exerted at the proximal hydrolysis site:18
a-Amylases recognise the reducing end (Fig. 3, blue), and a-
glucosidases (Fig. 3, red) process the structure from the non-
reducing end. Moreover, C2 uorination confers additional
advantages for carbohydrate drug design, by directing glyco-
sylation selectivity,11 and by providing an NMR active nucleus.19Fig. 2 The structure of generic maltodextrins and the location of
enzymatic hydrolysis by a-glucosidase and a-amylase.
Chem. Sci.In the uorinated structures, both C2 epimers were
conceived (gluco- and manno-congured, 3–6) to explore the
importance of the stereochemical information encoded at C2. A
2-deoxy species (2) at the non-reducing end was also envisaged
as a bioisosteric control species. This would enable the effect of
hydrogen bond deletion (C–OH / C–F and C–H) and of partial
charge inversion (C–Hd+ / C–Fd) to be assessed.
It is pertinent to note that the rarity of uorinated natural
products has the logical consequence that very few enzymes
have evolved to recognise this structural feature.20 Collectively,
it was envisaged that site-selectively uorinated sugars would
behave differently compared to their natural counterparts,
thereby altering the bound orientation without completely
suppressing function.Results and discussion
Docking studies with human a-amylase
To explore this notion, a computational docking study was
performed using the HYDE binding assessment calculation in
LeadIT/SeeSAR21 to predict the bound conformations of these
uorinated probes in human a-amylases and a-glucosidases.
Based on the sequence alignment and structural superimposi-
tion of salivary a-amylase (PDB ID: 1SMD)22 and pancreatic a-
amylase (PDB ID: 5U3A),23 it is clear that both structures display
a high degree of sequence and structural similarity, especially at
the active site. As 5U3A (pancreatic a-amylase) has the highest
resolution (0.95 Å), it was used for these docking studies.This journal is © The Royal Society of Chemistry 2020
Fig. 4 Docking studies: (a) comparison between the native substrate 1 (orange) and deoxy-substrate 2 (blue) in the active site of human
pancreatic a-amylase (PDB ID: 5U3A); (b) comparison between substrate 1 (orange) and substrate 5 (blue); (c) comparison of bound substrate 1
(orange) and substrate 6 (blue); (c1) interaction of 1 with residues in the active site; (c2) interaction of 6 with residues in the active site; (d)
comparison between substrate 1 (orange) and substrate 3 (blue); (e) comparison between substrate 1 (orange) and substrate 4 (blue). Colour
code: protein surface: grey; protein skeleton: C: grey, O: red, N: blue; substrate 1: C: orange, O: red, substrate 2–6: C: blue, O: red, F: green. This
figure was generated using SeeSAR 9.1 (BioSolveIT).2
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View Article OnlineInitially, the bound conformations of the endogenous substrate
1 and the corresponding deoxy-analogue 2 were investigated in
human pancreatic a-amylase (Fig. 4a). Although subtle, this
analysis revealed that the deletion of a single hydrogen-bond
donor at C2 of the terminal oligosaccharide at the non-
reducing end inverts the orientation of the bound molecule in
a sub-pocket lined by Asp300, Glu233 and Asp197 residues.
Repeating this docking analysis with substrate 5 also revealed
a ip in substrate orientation, such that it is repositioned with
the uorinated reducing end situated away from the Asp356
residue (Fig. 4b). To explore the effect of the C2 conguration on
molecular orientation, the docked substrate 6 was then
compared to 1 in the active site of human pancreatic a-amylase.
The consequence of this subtle structural alteration was to re-
align the scaffolds as indicated in Fig. 4c. These data demon-
strate that the deletion or substitution of the C(sp3)–OH by
C(sp3)–F can be harnessed to programme the orientation in
which the enzyme binds the substrate. Remarkably, inverting
the conguration of this single C(sp3)–F centre causes a ip in
the bound orientation that resembles the native substrate 1.
Although substrate 6 adopts the same general orientation as 1,
a distinct conformation results in which the non-reducing end
is positioned away from the Asp-356 residue. On a structural
level, the absence of the C2 hydrogen bond donor at the
reducing end eliminates the crucial interaction with Glu-233
(Fig. 4, inlayed Fig. c1 and c2). To examine the effects of
molecular editing with uorine at the non-reducing end,
substrates 3 and 4 were examined (Fig. 4d and e). Docking
studies reveal that substrate 3 (gluco-congured) adopts an
orientation that is similar to that of the native substrate 1 in theThis journal is © The Royal Society of Chemistry 2020active site of the pocket. As is evident from Fig. 4d, the non-
reducing end is positioned away from Asp-356.
Finally, an examination of substrate 4 (manno-congured)
revealed a bound conformation in which the molecular orien-
tation is similar to the native substrate 1 in the active site.
However, the reducing terminus is no longer in close proximity
to Asp-300, Glu-233 and Asp-197 (Fig. 4e) and the substrate is
generally shied outwards from the pocket. These docking
studies in a-amylase illustrate that molecular editing alters the
bound substrate orientation. The absence of these key interac-
tions may thus have a downstream effect on hydrolytic stability.Docking studies in human a-glucosidase
The bound conformation of substrate 1 and its deoxy-analogue
2 was subsequently investigated in a human intestinal a-
glucosidase enzyme (maltase-glucoamylase, PDB ID: 2QMJ).24
Contrary to the bound conformation in a-amylase, the deoxy-
substrate 2 was found to be oriented similarly to substrate 1
in the active site (Fig. 5a). Nonetheless, due to the deletion of
the OH group relative to 1, a crucial interaction with Asp-542 is
precluded (Fig. 5f, sub. 1 and sub. 2). Substrates 3 and 4 are
oriented similarly as substrate 1 in the active site (Fig. 5b and f
sub. 3; Fig. 5c and f sub. 4). In line with the ndings pertaining
to substrate 2, the bound conformations of uorinated probes 3
and 4 (OH / F) also lack the crucial interaction with Asp-542
(Fig. 5f, sub. 1 vs. sub. 3 and sub. 4). Oligosaccharides 5 and 6
adopt bound conformations that are similar to that of substrate
1 in the active site (Fig. 5d and e). This docking analysis did not
reveal signicant differences in the interactions of substrates 1
and 5 or 6 with key active site residues (Fig. 5f, subs 1, 5 and 6).Chem. Sci.
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View Article OnlineSynthesis of the probes 2–6
With a view to exploring the structural ramications of deletion
and uorination on the stability of these probes towards the
target enzymes, a concise synthetic route was conceived
(Schemes 1 and 2). The synthesis of the cores 10 and 11 was
achieved by treating maltotriose 7 with benzaldehyde dimethyl
acetal to generate the benzylidene acetal and subsequent global
acetate protection of the trisaccharide (8) (Scheme 1, top).
Cleavage of the acetal to unmask positions C4 and C6 allowed
for regioselective protection of the primary alcohol affording 10
and 11 thereby completing this synthesis of the glycosyl
acceptor.
Completion of this divergent [3 + 1] strategy was contingent
on the preparation of themodied glycosyl donors 12, 13 and 14
(for full preparative details see the ESI‡). These thioglycosides
proved to be highly a-selective thereby facilitating the synthesis
of the tetraose cores 15, 16 and 17.
Global deprotection proved facile to provide compounds 2
(2-deoxy), 3 (gluco-F) and 4 (manno-F) for biological evaluation.Fig. 5 Docking studies: (a) comparison between substrate 1 (orange) an
(PDB: 2QMJ); (b) comparison between substrate 1 (orange) and substrate
(blue); (d): comparison between substrate 1 (orange) and substrate 5 (blue
sub. 1–6: interactions of 1–6 with residues in the active site; colour co
substrate 1: C: orange, O: red; substrate 2–6: C: blue, O: red, F: green.
Chem. Sci.Modication of the reducing end required an adapted glycosyl
donor derived from 7. Per-acetylation (18) and thioglycoside
formation (19) was followed by global deprotection (Ac)/
protection (Bn) sequence (20). Independent a(1 / 4) glycosyl-
ation with acceptors 21 and 22 furnished the protected scaffolds
23 and 24, respectively. The desired tetraose derivatives 5 and 6
were obtained by benzyl deprotection and subsequent acetate
cleavage.Enzyme assays
To evaluate the inuence of site-selective uorine introduction
on hydrolytic stability, oligosaccharides 1–6 were incubated in
human and murine blood serum (please see the ESI‡ for full
details). The diversity of glycan-degrading enzymes in serum
renders the identication of specic enzymes challenging.
Therefore, the stability of maltotetraose conjugates 1–6 was
independently examined by incubation with puried a-amylase
and a-glucosidase. Both human and murine blood serum
contain large concentrations of hydrolytic enzymes whichd substrate 2 (blue) in the active site of human intestinal a-glucosidase
3 (blue); (c) comparison between substrate 1 (orange) and substrate 4
); (e) comparison between substrate 1 (orange) and substrate 6 (blue); (f)
de: protein surface: grey; protein skeleton: C: grey, O: red, N: blue;
This figure was generated using SeeSAR 9.1 (BioSolveIT).21
This journal is © The Royal Society of Chemistry 2020
Scheme 1 Preparation of fluorinatedmaltotetraose cores 3 and 4, and
the control system 2. Conditions: (a) (1) Benzaldehyde dimethyl acetal,
p-TsOH, DMF, 4 h, 50 C, 150 mbar; (2) Ac2O, DMAP, pyridine, 4 h, RT,
69% over two steps. (b) TFA/H2O (10 : 1), CH2Cl2, RT, 98%. (c) Acetyl
chloride, HOBt, TEA, CH2Cl2, RT, 76%. (d) Benzoyl chloride, pyridine,
3 h,10 C, 57%. (e) NIS, TMSOTf, CH2Cl2, 15min, RT, 15: 33%, 16: 50%,
17: 11%. (f) NaOMe, MeOH, RT, 3: 69%, 4: 86%, 2: 94%.
Scheme 2 Preparation of fluorinated maltotetraose cores 5 and 6.
Conditions: (a) Ac2O, DMAP, pyridine, 4 h, RT, 88%. (b) 4-Methyl-
benzenethiol, BF3$OEt2, CH2Cl2, 23 h, RT, 78%. (c) (1) NaOMe, MeOH,
2 h, RT, 91%; (2) NaH, BnBr, TBAI, DMF, 20 h, RT, 77%. (d) NIS, BF3$OEt2,
CH2Cl2, 15 min, RT, 23: 21%, 24: 25%. (e) Pd/C, H2, MeOH, EtOAc, 24 h,
RT; (f) NaOMe, MeOH, 8 h, RT, 5: 88%, 6: 67% over two steps.
Edge Article Chemical Science
O
pe
n 
A
cc
es
s 
A
rt
ic
le
. P
ub
lis
he
d 
on
 2
3 
N
ov
em
be
r 
20
20
. D
ow
nl
oa
de
d 
on
 1
2/
16
/2
02
0 
4:
25
:4
8 
PM
. 
 T
hi
s 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
C
om
m
on
s 
A
ttr
ib
ut
io
n-
N
on
C
om
m
er
ci
al
 3
.0
 U
np
or
te
d 
L
ic
en
ce
.
View Article Onlinebelong to the a-amylase family. It is pertinent to highlight that
the concentration in murine serum is considerable.7b This is
a consequence of the starch-based diets of small rodents. The
stability of the oligosaccharides was established by measuring
the liberation of glucose following incubation at 37 C over one
or ve hours (puried enzymes or blood serum, Fig. 6 and 7,
respectively). At each time point, the glucose level of a 0.6 mL
aliquot was measured with a point-of-care glucose meter
(ACCU-CHEK®-Inform II; Roche Diagnostic GmbH).
In both serum test series, wildtype maltotetraose 1 led to the
highest release of glucose, followed by the conjugates 5 and 6,
which are uorinated at the reducing end. Modications at the
non-reducing terminus (3 and 4) led to a remarkable stability
enhancement, compared to maltotetraose 1. The importance of
the C2 conguration also became apparent, with the gluco-
congured probe 3 displaying an approximate 5-fold decrease
in hydrolysis (murine blood serum) compared to 1, and out-
competing the corresponding epimer 4. The sensitivity of
enzyme catalysis towards changes at C2 is further evident from
the results of the deletion probe 2, which broadly mirrored theThis journal is © The Royal Society of Chemistry 2020stability of the manno-congured system 4. In comparison to
murine serum incubation, the glucose levels resulting from
human blood serum incubation are signicantly lower reect-
ing the comparatively lower enzyme concentration of 28–100
units per litre. Gratifyingly, in all of the synthetic maltotetraose
derivatives (2–6), enhanced hydrolytic stability was observed
with the uorinated conjugate 3 being entirely stable in human
blood serum. The translational implications of this nding are
noteworthy, particularly in the eld of bacterial imaging.
To explore the stability of the probe molecules in a more
controlled environment, the conjugates were incubated in
puried a-amylase and a-glucosidase solutions to quantify the
effect of a site-selective uorine installation (Fig. 7). In the case
of a-amylase, a stock solution of 2000 units per litre in heat-
inactivated blood serum was prepared and the experiments
were conducted at 37 C with gentle agitation.
Natural maltotetraose was rapidly truncated affording
a substantial glucose release of 110 mg dL1. All of the synthetic
conjugates exhibited notably improved hydrolytic stability with
conjugates 3 (non-reducing gluco-, 14 mg dL1) and 4 (non-
reducing manno-, 12 mg dL1) being the most robustChem. Sci.
Fig. 6 Hydrolytic stability of 1–6 in murine and human blood serum.
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View Article Onlinescaffolds. Given that a-amylase hydrolyses maltodextrin from
the reducing end, it is curious that modication at the opposite
terminus proved to be most crucial for substrate stability. For
completeness, this investigation was conducted with puried
acid-a-glucosidase, which metabolises maltodextrins from the
non-reducing end. In line with previous observations, the
incubation of wildtype maltotetraose resulted in the fastest
hydrolysis observed in this study. Interestingly, the 2-deoxy
species 2 showed comparable lability to maltotetraose when
incubated with a-glucosidase. The two uorinated conjugates 3
and 4 showed comparable behaviour, with a glucose concen-
tration of 5 mg dL1 having been measured aer an incubationFig. 7 Hydrolytic stability of maltotetraose conjugates in stock solu-
tions of a-amylase (2000 U L1, top) and a-glucosidase (10 U L1,
bottom).
Chem. Sci.time of 1 hour. Again, uorination at the reducing end (5 and 6)
led to enhanced stability in agreement with the results obtained
in the a-amylase assay. Interestingly, tetrasaccharide 5, bearing
a 2-deoxy-2-uoroglycosyl subunit at the reducing end, proved
to be most stable, releasing a glucose concentration of 1 mg
dL1. The key kinetic parameters pertaining to the probes
analysed in this study were investigated. Values of kcat were
determined by dividing vmax values by enzyme concentration
using a molecular weight of 53 000 (amylase) and 63 000
(glucosidase). The catalysed degradation of maltotetraose was
initiated by addition of 50–5000 units and 1–100 U enzyme,
respectively. Two So concentrations of around 0.1  Km were
used to ensure that substrate hydrolysis was linear with time.
The kinetic parameters for the hydrolysis of compounds by a-Table 1 Key kinetic parameters and DDG‡ for hydrolysis of maltote-
traose and derivatives
Enzyme/substrate
vmax (mM  U1  s1)/Kma
(mM) DDG‡b (kJ mol1)
a-Glucosidase
1 4  104 —
2 3.8  105 1.9
3 2.1  105 26.5
4 0.3  105 29.2
5 1.5  109 52.2
6 2.7  107 48.2
a-Amylase
1 7.7  103 —
2 3.1  104 2.8
3 2.6  104 23.4
4 3.8  104 24.6
5 8.9  104 27.2
6 7.6  104 29.7
a vmax/Km (s
1  U1) ¼ vo/EoSo; vo initial reaction rate of hydrolysis, Eo
enzyme amount in units, So initial substrate concentration,
determination at 37 C in heat inactivated serum. b DDG‡ ¼ RT ln
[(vmax/Km)derivat/(vmax/Km)maltotetraose] ¼ activation energy increase due
to the modied substrate (R gas constant; T absolute temperature)
according to the literature;25 vmax (the maximum reaction rate) and Km
(Michaelis constant; parameter of the enzyme's affinity for the
substrate) were determined by tting initial rates at different
substrate concentrations from 0.1  Km to 4  Km to the Michaelis–
Menten equation.26
This journal is © The Royal Society of Chemistry 2020
Fig. 10 A summary of this study and comparison of 1, 5 and 3.Fig. 8 X-ray analysis. Surface representation of a-amylase (blue) with
two maltose molecules at the active site (sticks, yellow carbon atoms).
A polder map contoured at 3s is shown as a grey isomesh. Asp300 is
shown as sticks (see modelling for comparison).
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View Article Onlineamylase and a-glucosidase are summarised in Table 1. These
were performed by quantitating the glucose formed as a reac-
tion product using glucose dehydrogenase electrochemical
detection technique. DDG‡ determined from vmax/Km values
indicates transition state destabilisation for a given probe
relative to the model substrate 1. DDG‡ for the two analogs with
uorine substituents located at the non-reducing end (3, 4) was
in the range 23.1–29.2 kJ mol1 and for the uorinated conju-
gates 5 and 6 between 27.2-52.2 kJ mol1 for the a-glucosidase
and for a-amylase, respectively (Table 1).
Finally, to glean additional insights into the fate of the
tetraose, we attempted to determine the crystal structure of
candidate 5 in complex with human a-amylase (see ESI online
information for details‡). Co-crystallisation of a-amylase with
5 did not yield electron density for a carbohydrate-like ligand
in the proximity of the active-site, so soaking was employed.
Data were collected for several crystals and the dataset with
clearest electron density for ligands was selected. This crystal
allowed data collection to 1.40 Å with excellent statistics (DataFig. 9 X-ray analysis. Cartoon representation of the co-crystal of a-
amylase (cyan) with two symmetry mates (violet and yellow). Carbo-
hydrates are shown as sticks. Maltose units that facilitate crystal
contacts are shownwith carbon atoms colored in blue, while the other
twomaltose molecules and the glucose have carbon atoms colored in
black.
This journal is © The Royal Society of Chemistry 2020collection and renement statistics can be found in Table 1 in
the ESI‡).
To our surprise, we did not nd electron density for 5, but
were able to identify four maltose molecules and one glucose
molecule in the structure. Two maltose molecules are bound at
the active-site (Fig. 8), while the other two facilitate crystal
contacts between symmetry mates (Fig. 9). Given the very high
protein concentration and long incubation time (soaking had to
be done for 48 h at 291 K), it is possible that the majority of 5
had degraded. What is intriguing is the presence of maltose
units, which may indicate an alternative cleavage site for the
uorinated maltotetraose that results in the very slow degra-
dation observed in biochemical assays. Our data do not hint at
the fate of the uorinated sugar moiety, and we cannot exclude
that the observed maltose units are in fact intact 5 with disor-
dered reducing and non-reducing ends. However, if that were
the case, the mode of binding of 5 to a-amylase would still be
distinct from that of the natural substrate and support the
conclusion that uorination at a single site can have a stabilis-
ing effect on maltotetraoses.Conclusions
In conclusion, the effect of molecular editing with uorine on
the bound conformation and resulting hydrolytic stability of
maltotetraoses has been assessed. In contrast to natural mal-
totetraose (1), these conjugates display enhanced metabolic
stability towards murine and human blood serum as well as a-
amylase and a-glucosidase. The seemingly innocent effect of
subtle physicochemical alterations arising from OH / F
substitution are sufficient to alter enzyme – small molecule
recognition, and this may prove to be expansive in a trans-
lational sense.
Alterations of the molecule at the opposite end to where
enzymatic cleavage occurs actively suppress catalysis (Fig. 10).
This phenomenon manifested itself in both assays, whereby
uorination at the “wrong” end of the chain resulted in the
greatest hydrolytic stability of the study. Collectively, these data
have enabled two probes (3 and 5) to be identied in which
stability is enhanced by one order of magnitude relative to the
native scaffold. Given the intimate regulatory role that amylasesChem. Sci.
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View Article Onlineplay in metabolic regulation, (e.g., Pompe disease, diabetes and
Parkinson's disease),27 their diagnostic signicance, and clin-
ical translation to bacterial imaging, it is envisaged that these
ndings may begin to reconcile the intrinsic hydrolytic insta-
bility of complex carbohydrates with their unrealised clinical
potential.
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